S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-01
DOI
10.3389/fimmu.2018.01216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis
- (2017) Hong Xia et al. JOURNAL OF CLINICAL INVESTIGATION
- Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
- (2017) Alexander V. Misharin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune Mechanisms in Pulmonary Fibrosis
- (2016) Saeed Kolahian et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages
- (2016) S Chen et al. CELL DEATH AND DIFFERENTIATION
- Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species–Induced Mouse Model
- (2016) Florence Morin et al. JOURNAL OF IMMUNOLOGY
- Nintedanib and Pirfenidone. New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis
- (2015) Claudia A. Staab-Weijnitz et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- S100A4 promotes liver fibrosis via activation of hepatic stellate cells
- (2015) Lin Chen et al. JOURNAL OF HEPATOLOGY
- Anatomy of a Discovery: M1 and M2 Macrophages
- (2015) Charles Dudley Mills Frontiers in Immunology
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
- (2012) Isis E Fernandez et al. LANCET
- Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
- (2011) U. Sack et al. JNCI-Journal of the National Cancer Institute
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells
- (2011) Ulrike Sack et al. MOLECULAR BIOLOGY OF THE CELL
- Worm Cure Without Tears
- (2010) Jørn Ditzel et al. ACTA MEDICA SCANDINAVICA
- Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
- (2010) Kusum V. Pandit et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
- (2010) C. H. Osterreicher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- S100A4 and Metastasis
- (2009) Kjetil Boye et al. AMERICAN JOURNAL OF PATHOLOGY
- Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma
- (2009) Raffi Tachdjian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney
- (2008) Shuei-Liong Lin et al. AMERICAN JOURNAL OF PATHOLOGY
- Disease-Specific Gene Expression Profiling in Multiple Models of Lung Disease
- (2007) Christina C. Lewis et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started